ArticleBlood2024

Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas.

Stephen J Schuster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.